EXTON,
Pa., March 5, 2025 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, today
announced that it will present at the Barclays 27th Annual Global
Healthcare Conference on Wednesday, March
12, 2025 at 11:00 AM ET.
It will also present at the KBCM Healthcare Forum on
Wednesday, March 19, 2025
at 1:30 PM ET.
A live audio webcast of these events will be available in the
"Investors" section of the Company's website at www.westpharma.com.
Replay of the webcasts will be available for approximately 90 days
after the events.
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With over
10,000 team members across 50 sites including 25 manufacturing
facilities worldwide, West helps support our customers by
delivering over 41 billion components and devices each
year.
Headquartered in Exton,
Pennsylvania, West in its fiscal year 2024 generated
$2.89 billion in net sales. West is
traded on the New York Stock Exchange (NYSE: WST) and is included
on the Standard & Poor's 500 index. For more information, visit
www.westpharma.com.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or its
subsidiaries, in the United States and other jurisdictions, unless
otherwise noted.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-to-participate-in-upcoming-investor-conferences-302391890.html
SOURCE West Pharmaceutical Services, Inc.
